Jang Hae-Dong, Kim Eung-Ha, Lee Jae Chul, Choi Sung-Woo, Kim Hak Soo, Cha Joong-Suk, Shin Byung-Joon
Department of Orthopaedic Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
Department of Orthopaedic Surgery, Dongkang Hospital, Ulsan, Korea.
Asian Spine J. 2022 Dec;16(6):934-946. doi: 10.31616/asj.2022.0441. Epub 2022 Dec 27.
A vertebral fracture is the most common type of osteoporotic fracture. Osteoporotic vertebral fractures (OVFs) cause a variety of morbidities and deaths. There are currently few "gold standard treatments" outlined for the management of OVFs in terms of quantity and quality. Conservative treatment is the primary treatment option for OVFs. The treatment of pain includes short-term bed rest, analgesic medication, anti-osteoporotic medications, exercise, and a brace. Numerous reports have been made on studies for vertebral augmentation (VA), including vertebroplasty and kyphoplasty. There is still debate and controversy about the effectiveness of VA in comparison with conservative treatment. Until more robust data are available, current evidence does not support the routine use of VA for OVF. Despite the fact that the majority of OVFs heal without surgery, 15%-35% of patients with an unstable fracture, persistent intractable back pain, or severely collapsed vertebra that causes a neurologic deficit, kyphosis, or chronic pseudarthrosis frequently require surgery. Because no single approach can guarantee the best surgical outcomes, customized surgical techniques are required. Surgeons must stay current on developments in the osteoporotic spine field and be open to new treatment options. Osteoporosis management and prevention are critical to lowering the risk of future OVFs. Clinical studies on bisphosphonate's effects on fracture healing are lacking. Teriparatide was intermittently administered, which dramatically improved spinal fusion and fracture healing while lowering mortality risk. According to the available literature, there are no standard management methods for OVFs. More multimodal approaches, including conservative and surgical treatment, VA, and medications that treat osteoporosis and promote fracture healing, are required to improve the quality of the majority of guidelines.
椎体骨折是最常见的骨质疏松性骨折类型。骨质疏松性椎体骨折(OVF)会引发多种疾病和死亡。目前,在数量和质量方面,针对OVF的管理几乎没有概述的“金标准治疗方法”。保守治疗是OVF的主要治疗选择。疼痛治疗包括短期卧床休息、止痛药物、抗骨质疏松药物、运动和支具。关于椎体强化(VA)的研究已有大量报道,包括椎体成形术和后凸成形术。与保守治疗相比,VA的有效性仍存在争议。在有更有力的数据之前,目前的证据不支持常规使用VA治疗OVF。尽管大多数OVF无需手术即可愈合,但15%-35%的不稳定骨折、持续性顽固性背痛或严重塌陷椎体导致神经功能缺损、脊柱后凸或慢性假关节形成的患者通常需要手术。由于没有单一方法能保证最佳手术效果,因此需要定制手术技术。外科医生必须紧跟骨质疏松性脊柱领域的发展,并接受新的治疗选择。骨质疏松症的管理和预防对于降低未来发生OVF的风险至关重要。关于双膦酸盐对骨折愈合影响的临床研究尚缺乏。间歇性使用特立帕肽可显著改善脊柱融合和骨折愈合,同时降低死亡风险。根据现有文献,OVF没有标准的管理方法。需要更多的多模式方法,包括保守和手术治疗、VA以及治疗骨质疏松症和促进骨折愈合的药物,以提高大多数指南的质量。